Pinned
Thrilled to finally share some significant Octant milestones today, including our $80 million Series B funding led by @CatalioCapital
bit.ly/37zxHFt
- Applications are now open for the Octant Apprenticeship program! It's a one-year, full-time research experience in chemistry, multiplexed assays, bioinformatics and synthetic biology. Be a part of a fast-paced, biotech startup with us! Apply here: octant.bio/jobs
- "This is the year the promise of synthetic biology in healthcare finally arrived." Read more 'Reflections on Moving Fast During a Pandemic' from our co-founder @srikosuri octant.bio/blog/reflectio…
- Our first installment of Octant's Art Series showcases how we turn our data into works of art. The images are Will from our Platform team's art piece compared to the actual platform run that inspired the art. Yeah, we think it looks like a subway map too.
- From our team to our platform to our drug discovery programs, 2022 was a year of massive growth @OctantBio. We made strides on challenging problems and didn't forget to have fun along the way. For a closer look, check out this blogpost! octant.bio/blog-posts/tha…
- We generate and screen ~6-9k novel compounds per week for each of our drug programs. Stacie is operating our robot arm to feed plates into the acoustic liquid handler, which will dispense the reagents for nanoliter-scale chemical reactions. #IntheLab
- Happening now at Octant HQ! Women in Science panel discussion to close out #WomensHistoryMonth. Thank you to @PracheeAC for joining us from @ArcadiaScience
- We’re thrilled to finally share OCTOPUS: A simple, low-cost plasmid sequencing method octant.bio/blog/2019/9/29… We think this will help molecular biology teams scale faster. Let us know what you think.
- We previously announced a partnership with Bristol Myers Squibb and this week we had a few Octonauts in Boston giving an update on our progress over the past year!
- Since its start in 2019, our apprenticeship program has transformed 27 fresh college grads into meaningful contributors at Octant. Check out our latest blog to learn how you can launch careers and turn new grads into biotech superstars, too! octant.bio/blog-posts/ope…
- Jeff from our Platform team helped create this artwork inspired by a multiplexed assay platform result testing a series of key engineered cell lines. Jeff believes this piece “embodies the Octant technology at its core.”
- We’re looking for a Research Associate for Octant’s SwabSeq team! We are building a small, focused team to improve, operationalize, and deploy SwabSeq to enable affordable mass COVID-19 testing efforts. For more information and to apply, see octant.bio/job-descriptio…
- We open-sourced OCTOPUS, our scalable NGS-based method to verify plasmids, two years ago. Today,@willovvens and Bryan are sharing powerful new features and updates on how OCTOPUS has evolved since then. bit.ly/3wclXme
- Check out this blogpost by @MollyGasp and @winnieLLiu! They share how @OctantBio multiplexed tech accelerates the tech dev of our drug discovery platform. First half for lay-audiences, parts II-V for scientists! octant.bio/blog/2021/1/11…
